+ All Categories
Home > Education > SMi Group's 6th annual BioBanking 2016 conference

SMi Group's 6th annual BioBanking 2016 conference

Date post: 16-Apr-2017
Category:
Upload: dale-butler
View: 309 times
Download: 1 times
Share this document with a friend
6
www.bio-banking-event.com Register online or fax your registration to +44 (0) 870 9090 712 or call +44 (0) 870 9090 711 @SMIPHARM #BioBankingSMi CHAIRS: • Emma Snapes, Biobank Manager, Infant Biobank • Dr Brian Thomson, Director and Clinical Lead for 100K Genome Project, Nottingham Health Science Biobank KEYNOTE SPEAKERS INCLUDE: • Professor Glyn Stacey, Director, UK Stem Cell Bank, Division of Advanced Therapies, National Institute for Biological Standards and Control - MHRA • Octavi Quintana Trias, Principal Advisor of DG, European Commission • Dr Julia Riedlinger, Head of Marker Scouting and Sample Bank, Roche Diagnostics • Arthur Lewis, Senior R&D Manager, MedImmune • Dr Michael Luntang-Jensen, Biobank Manager, H. Lundbeck A/S • Jonathan Sellors, Legal Counsel, UK Biobank BENEFITS OF ATTENDING IN 2016: Spotlight session - Creating a biobank for drug discovery • Hear the latest updates on Data Protection Act from European Commission and UK Biobank • Learn about the integration of biobanking in drug development • Obtain an overview of how to build and design a model of next generation biobank • Discover the latest updates on biobanking in the 21st Century 20TH-21ST JUNE 2016 HOLIDAY INN KENSINGTON FORUM, LONDON, UK SMi presents the 6th annual… BioBanking Ensuring compliance through regulatory updates and its impact on biobanking BOOK BY 31ST MARCH TO SAVE £400 • BOOK BY 29TH APRIL TO SAVE £300 • BOOK BY 27TH MAY 2016 AND SAVE £200 HEAR FROM MHRA, EUROPEAN COMMISSION PLUS LEADING EUROPEAN BIOBANKS!
Transcript
Page 1: SMi Group's 6th annual BioBanking 2016 conference

www.bio-banking-event.comRegister online or fax your registration to +44 (0) 870 9090 712 or call +44 (0) 870 9090 711

@SMIPHARM#BioBankingSMi

CHAIRS:

• Emma Snapes, Biobank Manager, Infant Biobank

• Dr Brian Thomson, Director and Clinical Lead for 100K Genome Project, Nottingham Health Science Biobank

KEYNOTE SPEAKERS INCLUDE:

• Professor Glyn Stacey, Director, UK Stem Cell Bank, Division of Advanced Therapies, National Institute for Biological Standards and Control - MHRA

• Octavi Quintana Trias, Principal Advisor of DG, European Commission

• Dr Julia Riedlinger, Head of Marker Scouting and Sample Bank, Roche Diagnostics

• Arthur Lewis, Senior R&D Manager, MedImmune

• Dr Michael Luntang-Jensen, Biobank Manager, H. Lundbeck A/S

• Jonathan Sellors, Legal Counsel, UK Biobank

BENEFITS OF ATTENDING IN 2016:

• Spotlight session - Creating a

biobank for drug discovery

• Hear the latest updates on Data

Protection Act from European

Commission and UK Biobank

• Learn about the integration of

biobanking in drug development

• Obtain an overview of how to

build and design a model of next

generation biobank

• Discover the latest updates on

biobanking in the 21st Century

20TH-21ST

JUNE 2016HOLIDAY INN KENSINGTON FORUM, LONDON, UK

SMi presents the 6th annual…

BioBankingEnsuring compliance through regulatory updates and

its impact on biobanking

BOOK BY 31ST MARCH TO SAVE £400 • BOOK BY 29TH APRIL TO SAVE £300 • BOOK BY 27TH MAY 2016 AND SAVE £200

HEAR FROM MHRA, EUROPEAN COMMISSION

PLUS LEADING EUROPEAN BIOBANKS!

Page 2: SMi Group's 6th annual BioBanking 2016 conference

BioBanking Day One | 20th June 2016 www.bio-banking-event.com

8.30 Registration & Coffee

9.00 Chairman’s Opening RemarksEmma Snapes, Biobank Manager, Infant Biobank

OPENING ADDRESS 9.10 Biobanking in the 21st century: Where are we now?

• Public engagement • Ethics and regulatory issues• Sustainability• HarmonisationEmma Snapes, Biobank Manager, Infant Biobank

KEYNOTE ADDRESS9.50 Assuring long term supply chain of stem cells for future therapies

• The key issues relating to the cryo-conservation of stem cell cultures of human pluripotent stem cell lines are significant loss of viable cells during preservation and recovery, reproducibility and reliability of recovery from preservation and assuring appropriate storage quarantine procedures

• Establishing appropriate systems to ensure stable storage temperatures and suitable testing regimes for viability and recovery testing regimes are essential for operation of successful stem cell biobanks

• Requalification of stem cell banks over the long term will need to be considered, based on developing scientific knowledge and emerging issues

Prof Glyn Stacey, Director, UK Stem Cell Bank, Division of Advanced Therapies, National Institute for Biological Standards and Control – MHRA

10.30 Morning Coffee

BIOBANKING AS A BUSINESS

11.00 Auria Biobank – model for next generation biobanking• What does next generation biobanking mean?• Gain insight to the rewards of innovative biobanking• Sustainability by Public-Private Partnership and new

co-operation modelsHeli Salminen-Mankonen, Director, Auria Biobank

11.40 Designing a modern biobank• Formation of a biobank• Ethical and legal issues• Developing a sustainable business model• Personalised medicine vs general medicine• Maximising value thought publicityDr. Balwir Matharoo-Ball, Deputy Director of Nottingham Health Science Biobank, Nottingham University Hospital NHS Trust

12.20 Networking Lunch

THE POWER OF SAMPLES

1.30 Biomarker identification and validation – the crucial role

of samples

• Challenges of biomarker discovery and validation

• Access to well-characterised samples

• Sample and data quality

• Ethical considerations

Dr Julia Riedlinger, Head of Marker Scouting and Sample

Bank, Roche Diagnostics

2.10 Optimising clinical laboratory sample usage

• Focus on Science to maximise the use of every sample

• Adapt to legislation changes

• Optimising sample collection and analysis

Dr Catherine Mela, Director Clinical Sample Science,

AstraZeneca

2.50 Afternoon Tea

3.20 Human tissue driving biologics research

• Why is human tissue important - selecting relevant

therapeutic targets

• How is human tissue used for and how can bio banks

work with biopharma

• What is human tissue delivering to biologics research

Dr Arthur Lewis, Senior R&D Manager, MedImmune

4.00 Impact of brain bio-banking on Parkinson’s disease

research

• Shedding light on disease mechanisms

• Identification of drug targets

• Neuropathological confirmation of clinical diagnosis

Prof David Dexter, Director of Parkinson’s UK Tissue Bank,

Imperial College London

4.40 Chairman’s Closing Remarks and Close of Day One

Register online at www.bio-banking-event.com

SUPPORTED BY

SPONSORSHIP AND EXHIBITION OPPORTUNITIES

SMi offer sponsorship, exhibition, advertising and branding packages, uniquely tailored to complement your company’s marketing strategy. Prime networking opportunities exist to entertain, enhance and expand your client base within the context of an independent discussion specific to your

industry. Should you wish to join the increasing number of companies benefiting from sponsoring our conferences please call: Alia Malick on +44 (0) 20 7827 6168 or email: [email protected]

OFFICIAL MEDIA PARTNERS OFFICIAL PUBLICATIONS

Page 3: SMi Group's 6th annual BioBanking 2016 conference

BioBankingwww.bio-banking-event.com Day Two | 21st June 2016

8.30 Registration & Coffee

9.00 Chairman’s Opening RemarksDr Brian Thomson, Director and Clinical Lead for 100K Genome Project, Nottingham Health Science Biobank

ETHICAL AND REGULATORY LANDSCAPE

KEYNOTE OPENING ADDRESS9.10 Data Protection Act

• Revision of the latest changes• The effect on local projects• Ethical dilemma when sharing biobank data• Regulation and sustainability of biobanking in general Octavi Quintana Trias, Principal Advisor of DG, European Commission

9.50 Use of research data • The use of pseudo-anonymised participant data in

research, and common misunderstandings relating to such use in the application of the law on data protection and confidentiality

• Linkage between research data sets – common problems (and misunderstandings)

• The prevailing legal framework in the UK and how this will be impacted by the EU Data Protection Regulation

Jonathan Sellors, Legal Counsel, UK Biobank

10.30 Morning Coffee

HARMONISATION IN BIOBANKING

11.00 European Bank for induced Pluripotent Stem Cells (EBiSC): Creating a biobank for stem cells

• Why induced Pluripotent Stem Cells (iPSCs) represent an important new research tool

• How the (EBiSC) acts as a central repository for iPSC lines created across Europe

• The challenges encountered in building the bankAidan Courtney, Chief Executive Officer, Roslin Cell Sciences Ltd

11.40 European Bank for induced Pluripotent Stem Cells (EBiSC): International distribution and long-term sustainability

• Challenges of international distribution of cell lines• Creating and satisfying end user demand• Factors influencing long-term sustainability of biobanksDr Bryan Bolton, Head of Business Development, Culture Collection, Public Health England

12.20 Networking Lunch

1.30 Biobanking and genomic research in clinical trials:

Challenges and solutions in working with global health

authorities and IRB/IECs

• Discuss Merck’s clinical pharmacogenomic and

biobanking strategy

• Understand challenges in biobanking and conducting

genomic research in the context of global clinical trials

• Discuss strategies and solutions to manage requirements

from global health authorities and IRB/IECs

Dr Karina Bienfait, Head, Global Genomics Policy, Process

and Compliance, MSD

2.10 Integration of biobanking in drug development

• Organizational and logistic requirements for high quality

sample management

• Ethical and regulatory challenges

• Management responsibility and governance

Dr Michael Luntang-Jensen, Biobank Manager,

H. Lundbeck A/S

2.50 Afternoon Tea

3.20 Creating a UK biobanking network; the human and

technological challenges

• Biobanking in the UK - the need for transformation

• Realising the value of biobanks as platforms for precision

medicine

• The purpose of the UKCRC Directory

• How the Directory fits into the European programme

• The future - standardisation

Dr Brian Thomson, Director and Clinical Lead for 100K

Genome Project, Nottingham Health Science Biobank

Dr Phil Quinlan, Interim Director, UKCRC Tissue Directory

and Co-ordination Centre, University of Nottingham

4.00 The CCLG tissue bank: Experience from a national

children’s tumour bank

Dr Thomas Jacques, Chair CCLG Biological Studies

Steering Group, University College London

4.40 Chairman’s Closing Remarks and Close of Day Two

Alternatively fax your registration to +44 (0)870 9090 712 or call +44 (0)870 9090 711

SUPPORTED BY

Want to know how you can get involved? Interested in promoting your services to this market? Contact Honey de Gracia, SMi Marketing on

+44 (0)20 7827 6102 or email: [email protected]

SPOTLIGHTSESSION

Page 4: SMi Group's 6th annual BioBanking 2016 conference

Benefits of Sponsoring Biobanking 2016The industry has reached a tipping point and is about to enter the commercial stage. With lots of exciting opportunities ahead of biobanks, join our 6th annual Biobanking meeting to:

1. Showcase your biobanking services and products through keynote presentation to senior decision makers to help them overcome commercial challenges

2. Leverage your brand and exposure by exhibiting

3. Meet and network with senior decision makers – understand their priorities and how their businesses are developing

4. Engage with your prospects and foster growth with existing clients during our quality networking breaks

5. Ensure your service and product offerings fit with the industry’s today needs, and benefit from our tailored sponsorship packages

For further information, please contact Alia Malick, Director, on +44 (0) 20 7827 6168 or email: [email protected]

Past Years’ Attendees Profile by Sector

Register online at

www.bio-banking-event.com

Alternatively fax your registration to +44 (0)870 9090 712 or call +44 (0)870 9090 711

Pharma & Biotech 59.5%

Academia 16.2%

Consultancy 13.5%

Regulatory 10.8%

59.5%

13.5%

10.8%

16.2%

Page 5: SMi Group's 6th annual BioBanking 2016 conference

SMi PHARMACEUTICALEVENT PLANNER 2016

MARCH

Superbugs & Superdrugs - A Focus on Antibacterials16th - 17th MarchHoliday Inn Kensington Forum, London, UK

Paediatric Clinical Trials16th - 17th MarchHoliday Inn Kensington Forum, London, UK

APRIL

Asthma & COPD11th - 12th AprilHoliday Inn Kensington Forum, London, UK

Controlled Release18th - 19th AprilHoliday Inn Kensington Forum, London, UK

Adaptive Designs18th - 19th AprilHoliday Inn Kensington Forum, London, UK

Pre-Filled Syringes East Coast25th - 26th AprilRenaissance Woodbridge, New Jersey, USA

Lyophilization USA27th - 28th AprilRenaissance Woodbridge, New Jersey, USA

MAY

Alzheimer’s10th - 11th MayHoliday Inn Kensington Forum, London, UK

Clinical Trial Logistics18th - 19th MayHoliday Inn Kensington Forum, London, UK

Pain Therapeutics23rd - 24th MayHoliday Inn Kensington Forum, London, UK

ADC Summit 201623rd - 24th MayHoliday Inn Kensington Forum, London, UK

JUNE

Pre-Filled Syringes West Coast6th - 7th JuneHyatt Regency Mission Bay, San Diego, USA

ADMET13th - 14th JuneHoliday Inn Kensington Forum, London, UK

Immunogenicity13th - 14th JuneHoliday Inn Kensington Forum, London, UK

BioBanking20th - 21st JuneHoliday Inn Kensington Forum, London, UK

JULY

Lyophilisation Europe4th - 5th JulyHoliday Inn Kensington Forum, London, UK

Allergies6th - 7th JulyHoliday Inn Kensington Forum, London, UK

Peptides6th - 7th JulyHoliday Inn Kensington Forum, London, UK

Page 6: SMi Group's 6th annual BioBanking 2016 conference

Please complete fully and clearly in capital letters. Please photocopy for additional delegates.

Title: Forename:

Surname:

Job Title:

Department/Division:

Company/Organisation:

Email:

Company VAT Number:

Address:

Town/City:

Post/Zip Code: Country:

Direct Tel: Direct Fax:

Mobile:

Switchboard:

Signature: Date:I agree to be bound by SMi’s Terms and Conditions of Booking.

ACCOUNTS DEPT

Title: Forename:

Surname:

Email:

Address (if different from above):

Town/City:

Post/Zip Code: Country:

Direct Tel: Direct Fax:

BIOBANKINGConference: 20th - 21st June 2016, Holiday Inn Kensington Forum, London, UK

4 WAYS TO REGISTER

FAX your booking form to +44 (0) 870 9090 712

PHONE on +44 (0) 870 9090 711

ONLINE at www.bio-banking-event.com POST your booking form to: Events Team, SMi Group Ltd, 2nd Floor South, Harling House,

47-51 Great Suffolk Street, London, SE1 0BS

If you have any further queries please call the Events Team on tel +44 (0) 870 9090 711 or you can email them at [email protected]

Payment: If payment is not made at the time of booking, then an invoice will be issued and must be paid immediately and prior to the start of the event. If payment has not been received then credit card details will be requested and payment taken before entry to the event. Bookings within 7 days of event require payment on booking. Access to the Document Portal will not be given until payment has been received.

Substitutions/Name Changes: If you are unable to attend you may nominate, in writing, another delegate to take your place at any time prior to the start of the event. Two or more delegates may not ‘share’ a place at an event. Please make separate bookings for each delegate.

Cancellation: If you wish to cancel your attendance at an event and you are unable to send a substitute, then we will refund/credit 50% of the due fee less a £50 administration charge, providing that cancellation is made in writing and received at least 28 days prior to the start of the event. Regretfully cancellation after this time cannot be accepted. We will however provide the conferences documentation via the Document Portal to any delegate who has paid but is unable to attend for any reason. Due to the interactive nature of the Briefings we are not normally able to provide documentation in these circumstances. We cannot accept cancellations of orders placed for Documentation or the Document Portal as these are reproduced specifically to order. If we have to cancel the event for any reason, then we will make a full refund immediately, but disclaim any further liability.

Alterations: It may become necessary for us to make alterations to the content, speakers, timing, venue or date of the event compared to the advertised programme.

Data Protection: The SMi Group gathers personal data in accordance with the UK Data Protection Act 1998 and we may use this to contact you by telephone, fax, post or email to tell you about other products and services. Unless you tick here □ we may also share your data with third parties offering complementary products or services. If you have any queries or want to update any of the data that we hold then please contact our Database Manager [email protected] or visit our website www.smi-online.co.uk/updates quoting the URN as detailed above your address on the attached letter.

Unique Reference Number

Our Reference P-174

Terms and Conditions of Booking

DELEGATE DETAILS

Payment must be made to SMi Group Ltd, and received before the event, by one of the following methods quoting reference P-174 and the delegate’s name. Bookings made within 7 days of the event require payment on booking, methods of payment are below. Please indicate method of payment:□ UK BACS Sort Code 300009, Account 00936418□ Wire Transfer Lloyds TSB Bank plc, 39 Threadneedle Street, London, EC2R 8AU Swift (BIC): LOYDGB21013, Account 00936418 IBAN GB48 LOYD 3000 0900 9364 18□ Cheque We can only accept Sterling cheques drawn on a UK bank.□ Credit Card □ Visa □ MasterCard □ American Express All credit card payments will be subject to standard credit card charges.

Card No: □□□□ □□□□ □□□□ □□□□Valid From □□/□□ Expiry Date □□/□□CVV Number □□□□ 3 digit security on reverse of card, 4 digits for AMEX card Cardholder’s Name:

Signature: Date:

I agree to be bound by SMi’s Terms and Conditions of Booking.

Card Billing Address (If different from above):

DOCUMENTATIONI cannot attend but would like to Purchase access to the following Document Portal/Paper Copy documentation. Price Total

□ Access to the conference documentation on the Document Portal £499.00 + VAT £598.80

□ The Conference Presentations – paper copy £499.00 - £499.00 (or only £300 if ordered with the Document Portal)

PAYMENT

VATVAT at 20% is charged on the attendance fees for all delegates. VAT is also charged on Document portal and literature distribution for all UK customers and for those EU Customers not supplying a registration number for their own country here

CONFERENCE PRICES GROUP DISCOUNTS AVAILABLE

I would like to attend: (Please tick as appropriate) Fee TOTAL

□ Conference £1499.00 + VAT £1798.80

PROMOTIONAL LITERATURE DISTRIBUTION

□ Distribution of your company’s promotional literature to all conference attendees £999.00 + VAT £1198.80

The conference fee includes refreshments, lunch, conference papers, and access to the Document Portal. Presentations that are available for download will be subject to distribution rights by speakers. Please note that some presentations may not be available for download. Access information for the document portal will be sent to the e-mail address provided during registration. Details are sent within 24 hours post conference.

VENUE Holiday Inn Kensington Forum, 97 Cromwell Road, London SW7 4DN

□ Please contact me to book my hotelAlternatively call us on +44 (0) 870 9090 711, email: [email protected] or fax +44 (0) 870 9090 712

□ Book by 31st March 2016 and save £400□ Book by 29th April 2016 and save £300□ Book by 27th May 2016 and save £200

EARLY BIRD DISCOUNT


Recommended